Provectus Pharmaceuticals Inc. Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Provectus Pharmaceuticals Inc.

PVCT 0.0650

0.0%

Nov 14 9:30 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: jm2i123 who wrote (12085)	6/13/2013 2:34:12 PM
From: dirkdiggler	Read Replies (1) of 13111

Here's the problem. 1. I wouldn't have any problem with the stock going down if Mgt came through on just one of their assertions. 2. All I heard after PII was AA. Then it switched to SPA. Which we were supposed to get according to Mgt End Q2 2012. Now there going for BTD. They could have an SPA start the trial and go for a BTD. 3. Regional and global deals. Let's take PFE as an example since I always here they are the ones that will buy them out. PFE wants bolt on businesses with means they want a company/drug they can acquire and put it directly into they sales pipeline. ie. Use their existing sales team for sell the drug with no additional cost. Ie the drug margin/cash flow goes directly to the bottom line. If PVCT does regions deal with different companies around the globe, that places a significant discount to the buy out price or might not even make PVCT attractive to PFE. Granted regional deals give PVCT capital to continue and will add to the share value but the maximum share price will never be achieved unless a 100% unconditional buyout is achieved. 4. I taken your advise and sold shares. Just make sure others don't sell as support is a 62 cents.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next